NRSN is trading at $0.79, up 12.1% versus the comparison close of $0.70 during after-hours. This is a price-movement alert; no separate company-specific catalyst was searched for this follow-up.
🟢 Neurosense Therapeutics Ltd makes sharp 12.1% jump
Neurosense Therapeutics Ltd
Related News
NRSN
NeuroSense Advances ALS Drug PrimeC, Reducing Protein Linked to 97% of Cases
NRSN
🔴 NRSN is trading 5.5% down today after meeting Phase 2b ALS study endpoint
NRSN
NeuroSense's Sub-Dollar Stock Gets a Jolt From Alzheimer's Data and Insider Cash — But Can an Eight-Patient Study Justify Real Conviction?
NRSN
🟢 NRSN is trading 3% up today ahead of Q1 earnings and positive clinical updates
NRSN